Sign in

CIK 0000842023

  • Large accelerated filer

BIO-TECHNE Corp

Sign in to watch
Ticker
TECH
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jun 30
Incorporated
MN
Entity type
Operating
EIN
411427402
Phone
+1 612-379-8854
Business address
614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
Former names
TECHNE CORP /MN/
  1. 4 Grant or award Director acquired 495 shares (grant or award)
  2. 4 Grant or award Director acquired 495 shares (grant or award)
  3. 4 Grant or award Director acquired 495 shares (grant or award)
  4. 4 Grant or award Director acquired 495 shares (grant or award)
  5. 4 Grant or award Director acquired 495 shares (grant or award)
  6. 4 Grant or award Director acquired 495 shares (grant or award)
  7. 4 Grant or award Director acquired 495 shares (grant or award)
  8. 4 Open-market buy Chief Executive Officer bought 200 shares at $185.00 ($37,000)
  9. 4 Shares withheld for taxes SVP - Novus Biologicals gave up 900 shares (to pay taxes)
  10. 4 Shares withheld for taxes Chief Financial Officer gave up 2,424 shares (to pay taxes)
  11. 4 Option exercise Chief Executive Officer acquired 24,979 shares (option exercise)
  12. 4 Shares withheld for taxes SVP - General Counsel gave up 745 shares (to pay taxes)
  13. 4 Option exercise Chief Executive Officer acquired 7,410 shares (option exercise)
  14. 4 Open-market buy Director bought 500 shares at $191.06 ($95,530)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Grant or award Chief Executive Officer acquired 11,291 shares (grant or award)
  20. 4 Open-market sale Chief Executive Officer sold 16,969 shares at an average $213.12 ($3,616,428)

Page 15 of 35 · 695 filings